Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 674 entries
Sorted by: Best Match Show Resources per page
Long-term treatment of chronic plaque psoriasis with biological drugs can control platelet activation: targeting the bridge between inflammation and atherothrombosis.

Postepy dermatologii i alergologii

Kwiek B, Narbutt J, Sysa-Jędrzejowska A, Langner A, Lesiak A.
PMID: 28507492
Postepy Dermatol Alergol. 2017 Apr;34(2):131-137. doi: 10.5114/ada.2017.67077. Epub 2017 Apr 13.

INTRODUCTION: Platelet activation is elevated in moderate to severe psoriasis, and the reduction in platelet activation during short-term treatment has already been demonstrated. Soluble P-selectin is a well-established marker of platelet activation.AIM: To show whether the long-term treatment of...

Cite
Kwiek B, Narbutt J, Sysa-Jędrzejowska A, et al. Long-term treatment of chronic plaque psoriasis with biological drugs can control platelet activation: targeting the bridge between inflammation and atherothrombosis. Postepy Dermatol Alergol. 2017;34(2):131-137doi: 10.5114/ada.2017.67077.
Kwiek, B., Narbutt, J., Sysa-Jędrzejowska, A., Langner, A., & Lesiak, A. (2017). Long-term treatment of chronic plaque psoriasis with biological drugs can control platelet activation: targeting the bridge between inflammation and atherothrombosis. Postepy dermatologii i alergologii, 34(2), 131-137. https://doi.org/10.5114/ada.2017.67077
Kwiek, Bartłomiej, et al. "Long-term treatment of chronic plaque psoriasis with biological drugs can control platelet activation: targeting the bridge between inflammation and atherothrombosis." Postepy dermatologii i alergologii vol. 34,2 (2017): 131-137. doi: https://doi.org/10.5114/ada.2017.67077
Kwiek B, Narbutt J, Sysa-Jędrzejowska A, Langner A, Lesiak A. Long-term treatment of chronic plaque psoriasis with biological drugs can control platelet activation: targeting the bridge between inflammation and atherothrombosis. Postepy Dermatol Alergol. 2017 Apr;34(2):131-137. doi: 10.5114/ada.2017.67077. Epub 2017 Apr 13. PMID: 28507492; PMCID: PMC5420605.
Copy Download .nbib Format: NLM
Effects of Local Pancreatic Renin-Angiotensin System on the Microcirculation of Rat with Severe Acute Pancreatitis.

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Pan Z, Feng L, Long H, Wang H, Feng J, Chen F.
PMID: 26170733
Korean J Physiol Pharmacol. 2015 Jul;19(4):299-307. doi: 10.4196/kjpp.2015.19.4.299. Epub 2015 Jun 30.

Severe acute pancreatitis (SAP) is normally related to multiorgan dysfunction and local complications. Studies have found that local pancreatic renin-angiotensin system (RAS) was significantly upregulated in drug-induced SAP. The present study aimed to investigate the effects of angiotensin II...

Cite
Pan Z, Feng L, Long H, et al. Effects of Local Pancreatic Renin-Angiotensin System on the Microcirculation of Rat with Severe Acute Pancreatitis. Korean J Physiol Pharmacol. 2015;19(4):299-307doi: 10.4196/kjpp.2015.19.4.299.
Pan, Z., Feng, L., Long, H., Wang, H., Feng, J., & Chen, F. (2015). Effects of Local Pancreatic Renin-Angiotensin System on the Microcirculation of Rat with Severe Acute Pancreatitis. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 19(4), 299-307. https://doi.org/10.4196/kjpp.2015.19.4.299
Pan, Zhijian, et al. "Effects of Local Pancreatic Renin-Angiotensin System on the Microcirculation of Rat with Severe Acute Pancreatitis." The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology vol. 19,4 (2015): 299-307. doi: https://doi.org/10.4196/kjpp.2015.19.4.299
Pan Z, Feng L, Long H, Wang H, Feng J, Chen F. Effects of Local Pancreatic Renin-Angiotensin System on the Microcirculation of Rat with Severe Acute Pancreatitis. Korean J Physiol Pharmacol. 2015 Jul;19(4):299-307. doi: 10.4196/kjpp.2015.19.4.299. Epub 2015 Jun 30. PMID: 26170733; PMCID: PMC4499641.
Copy Download .nbib Format: NLM
Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia.

Heart Asia

Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M.
PMID: 27326130
Heart Asia. 2013 Sep 13;5(1):204-9. doi: 10.1136/heartasia-2013-010368. eCollection 2013.

BACKGROUND: Pitavastatin is a statin with strong pleiotropic effects, but the effects of pitavastatin on endothelial cell function (ECF) and both inflammatory cytokines and chemokines have not been fully investigated.MATERIAL AND METHODS: We simultaneously measured brachial artery (BA) flow-mediated...

Cite
Takase B, Hattori H, Tanaka Y, et al. Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia. 2013;5(1):204-9doi: 10.1136/heartasia-2013-010368.
Takase, B., Hattori, H., Tanaka, Y., Nagata, M., & Ishihara, M. (2013). Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia, 5(1), 204-9. https://doi.org/10.1136/heartasia-2013-010368
Takase, Bonpei, et al. "Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia." Heart Asia vol. 5,1 (2013): 204-9. doi: https://doi.org/10.1136/heartasia-2013-010368
Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M. Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia. 2013 Sep 13;5(1):204-9. doi: 10.1136/heartasia-2013-010368. eCollection 2013. PMID: 27326130; PMCID: PMC4832709.
Copy Download .nbib Format: NLM
Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera.

Hematology (Amsterdam, Netherlands)

Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N.
PMID: 27426843
Hematology. 1999;4(5):397-402. doi: 10.1080/10245332.1999.11746464.

Vascular complications are the main cause of morbidity in polycythemia vera (PV) and essential thrombocythemia (ET). To investigate plasma concentrations of soluble P-selectin (sP-Sel.), soluble E-selectin (sE-Sel.) and soluble thrombomodulin (sTM) in relation to the presence of thromboembolic events...

Cite
Musolino C, Alonci A, Bellomo G, et al. Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology. 1999;4(5):397-402doi: 10.1080/10245332.1999.11746464.
Musolino, C., Alonci, A., Bellomo, G., Tringali, O., Spatari, G., Quartarone, C., Rizzo, V., Calabrò, L., Bagnato, G., & Frisina, N. (1999). Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology (Amsterdam, Netherlands), 4(5), 397-402. https://doi.org/10.1080/10245332.1999.11746464
Musolino, C, et al. "Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera." Hematology (Amsterdam, Netherlands) vol. 4,5 (1999): 397-402. doi: https://doi.org/10.1080/10245332.1999.11746464
Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N. Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology. 1999;4(5):397-402. doi: 10.1080/10245332.1999.11746464. PMID: 27426843.
Copy Download .nbib Format: NLM
OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?.

Thrombosis research

Faille D, Ajzenberg N, de Chaisemartin L, Granger V, Chollet-Martin S, de Raucourt E, Hammel P, Lévy P, Ruszniewski P, Rebours V.
PMID: 27161678
Thromb Res. 2016 Apr;140:S170-1. doi: 10.1016/S0049-3848(16)30123-2. Epub 2016 Apr 08.

INTRODUCTION: Venous thrombo-embolic events (VTE) occur frequently in patients with pancreatic cancer and contribute to elevated morbidity and mortality. Clinical risk factors for thrombosis such as cancer stage and tumor grade have been clearly identified. Recently, several biomarkers have...

Cite
Faille D, Ajzenberg N, de Chaisemartin L, et al. OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?. Thromb Res. 2016;140:S170-1doi: 10.1016/S0049-3848(16)30123-2.
Faille, D., Ajzenberg, N., de Chaisemartin, L., Granger, V., Chollet-Martin, S., de Raucourt, E., Hammel, P., Lévy, P., Ruszniewski, P., & Rebours, V. (2016). OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?. Thrombosis research, 140S170-1. https://doi.org/10.1016/S0049-3848(16)30123-2
Faille, D, et al. "OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?." Thrombosis research vol. 140 (2016): S170-1. doi: https://doi.org/10.1016/S0049-3848(16)30123-2
Faille D, Ajzenberg N, de Chaisemartin L, Granger V, Chollet-Martin S, de Raucourt E, Hammel P, Lévy P, Ruszniewski P, Rebours V. OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?. Thromb Res. 2016 Apr;140:S170-1. doi: 10.1016/S0049-3848(16)30123-2. Epub 2016 Apr 08. PMID: 27161678.
Copy Download .nbib Format: NLM
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status.

Thrombosis research

Vignoli A, Tessarolo S, Marchetti M, Gamba S, Piras F, Finazzi G, van der Meijden PE, Swieringa F, Ten Cate H, Heemskerk JW, Rambaldi A, Falanga A.
PMID: 27161708
Thromb Res. 2016 Apr;140:S183. doi: 10.1016/S0049-3848(16)30152-9. Epub 2016 Apr 08.

INTRODUCTION: The myeloproliferative neoplasms ET and PV are characterized by a high incidence of both arterial and venous thrombosis, and/or microcirculatory disturbances. Three somatic mutations, i.e. JAK2-V617F, Calreticulin (CalR) and MPL, commonly found in these diseases, correlate with different...

Cite
Vignoli A, Tessarolo S, Marchetti M, et al. PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status. Thromb Res. 2016;140:S183doi: 10.1016/S0049-3848(16)30152-9.
Vignoli, A., Tessarolo, S., Marchetti, M., Gamba, S., Piras, F., Finazzi, G., van der Meijden, P. E., Swieringa, F., Ten Cate, H., Heemskerk, J. W., Rambaldi, A., & Falanga, A. (2016). PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status. Thrombosis research, 140S183. https://doi.org/10.1016/S0049-3848(16)30152-9
Vignoli, A, et al. "PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status." Thrombosis research vol. 140 (2016): S183. doi: https://doi.org/10.1016/S0049-3848(16)30152-9
Vignoli A, Tessarolo S, Marchetti M, Gamba S, Piras F, Finazzi G, van der Meijden PE, Swieringa F, Ten Cate H, Heemskerk JW, Rambaldi A, Falanga A. PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status. Thromb Res. 2016 Apr;140:S183. doi: 10.1016/S0049-3848(16)30152-9. Epub 2016 Apr 08. PMID: 27161708.
Copy Download .nbib Format: NLM
Tissue-Specific Induction of CCR6 and Nrp1 During Early CD4.

European journal of microbiology & immunology

Pezoldt J, Huehn J.
PMID: 27766171
Eur J Microbiol Immunol (Bp). 2016 Aug 23;6(3):219-226. doi: 10.1556/1886.2016.00018. eCollection 2016 Sep 29.

Upon differentiation, T cells acquire tissue-specific homing properties allowing efficient targeting of effector T cells into distinct inflamed organs. Priming of T cells within skin-draining, peripheral lymph nodes (pLNs) leads to the expression of E- and P-selectin ligands, which...

Cite
Pezoldt J, Huehn J. Tissue-Specific Induction of CCR6 and Nrp1 During Early CD4. Eur J Microbiol Immunol (Bp). 2016;6(3):219-226doi: 10.1556/1886.2016.00018.
Pezoldt, J., & Huehn, J. (2016). Tissue-Specific Induction of CCR6 and Nrp1 During Early CD4. European journal of microbiology & immunology, 6(3), 219-226. https://doi.org/10.1556/1886.2016.00018
Pezoldt, Joern, and Huehn, Jochen. "Tissue-Specific Induction of CCR6 and Nrp1 During Early CD4." European journal of microbiology & immunology vol. 6,3 (2016): 219-226. doi: https://doi.org/10.1556/1886.2016.00018
Pezoldt J, Huehn J. Tissue-Specific Induction of CCR6 and Nrp1 During Early CD4. Eur J Microbiol Immunol (Bp). 2016 Aug 23;6(3):219-226. doi: 10.1556/1886.2016.00018. eCollection 2016 Sep 29. PMID: 27766171; PMCID: PMC5063015.
Copy Download .nbib Format: NLM
Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase.

Journal of cardiovascular and thoracic research

Saidi H, Vakilian M, Noori GH, Ghafouri HB, Abazarian N.
PMID: 24404343
J Cardiovasc Thorac Res. 2013;5(4):139-41. doi: 10.5681/jcvtr.2013.030. Epub 2013 Dec 05.

INTRODUCTION: The role of adhesion molecules in the development and progression of coronary atherosclerosis is inevitable. It is not clear yet whether these molecules increase or decrease in level after thrombolytic therapy. This study was designed to compare concentrations...

Cite
Saidi H, Vakilian M, Noori GH, et al. Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase. J Cardiovasc Thorac Res. 2013;5(4):139-41doi: 10.5681/jcvtr.2013.030.
Saidi, H., Vakilian, M., Noori, G. H., Ghafouri, H. B., & Abazarian, N. (2013). Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase. Journal of cardiovascular and thoracic research, 5(4), 139-41. https://doi.org/10.5681/jcvtr.2013.030
Saidi, Hossein, et al. "Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase." Journal of cardiovascular and thoracic research vol. 5,4 (2013): 139-41. doi: https://doi.org/10.5681/jcvtr.2013.030
Saidi H, Vakilian M, Noori GH, Ghafouri HB, Abazarian N. Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase. J Cardiovasc Thorac Res. 2013;5(4):139-41. doi: 10.5681/jcvtr.2013.030. Epub 2013 Dec 05. PMID: 24404343; PMCID: PMC3883535.
Copy Download .nbib Format: NLM
Serial changes in morphology and biochemical markers in platelet preparations with storage.

Asian journal of transfusion science

Jain A, Marwaha N, Sharma RR, Kaur J, Thakur M, Dhawan HK.
PMID: 25722572
Asian J Transfus Sci. 2015 Jan-Jun;9(1):41-7. doi: 10.4103/0973-6247.150949.

BACKGROUND: This study was designed to perform serial assessment of alterations in platelet (PLT) count, morphology and biochemical markers of PLT activation during storage of platelet concentrates (PCs) and to correlate morphological changes with these activation markers.MATERIALS AND METHODS:...

Cite
Jain A, Marwaha N, Sharma RR, et al. Serial changes in morphology and biochemical markers in platelet preparations with storage. Asian J Transfus Sci. 2015;9(1):41-7doi: 10.4103/0973-6247.150949.
Jain, A., Marwaha, N., Sharma, R. R., Kaur, J., Thakur, M., & Dhawan, H. K. (2015). Serial changes in morphology and biochemical markers in platelet preparations with storage. Asian journal of transfusion science, 9(1), 41-7. https://doi.org/10.4103/0973-6247.150949
Jain, Ashish, et al. "Serial changes in morphology and biochemical markers in platelet preparations with storage." Asian journal of transfusion science vol. 9,1 (2015): 41-7. doi: https://doi.org/10.4103/0973-6247.150949
Jain A, Marwaha N, Sharma RR, Kaur J, Thakur M, Dhawan HK. Serial changes in morphology and biochemical markers in platelet preparations with storage. Asian J Transfus Sci. 2015 Jan-Jun;9(1):41-7. doi: 10.4103/0973-6247.150949. PMID: 25722572; PMCID: PMC4339931.
Copy Download .nbib Format: NLM
Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease.

Pregnancy hypertension

Lazzarin N, Desideri G, Ferri C, Valensise H, Gagliardi G, Tiralongo GM, Manfellotto D.
PMID: 26105609
Pregnancy Hypertens. 2012 Oct;2(4):393-7. doi: 10.1016/j.preghy.2012.02.002. Epub 2012 Feb 29.

OBJECTIVE: There is emerging evidence suggesting that women who develop hypertensive disorders of pregnancy should be considered at risk for cardiovascular disease (CVD). Our objective was to determine whether persistent endothelial activation, which represents the earliest step in atherogenesis,...

Cite
Lazzarin N, Desideri G, Ferri C, et al. Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease. Pregnancy Hypertens. 2012;2(4):393-7doi: 10.1016/j.preghy.2012.02.002.
Lazzarin, N., Desideri, G., Ferri, C., Valensise, H., Gagliardi, G., Tiralongo, G. M., & Manfellotto, D. (2012). Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease. Pregnancy hypertension, 2(4), 393-7. https://doi.org/10.1016/j.preghy.2012.02.002
Lazzarin, Natalia, et al. "Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease." Pregnancy hypertension vol. 2,4 (2012): 393-7. doi: https://doi.org/10.1016/j.preghy.2012.02.002
Lazzarin N, Desideri G, Ferri C, Valensise H, Gagliardi G, Tiralongo GM, Manfellotto D. Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease. Pregnancy Hypertens. 2012 Oct;2(4):393-7. doi: 10.1016/j.preghy.2012.02.002. Epub 2012 Feb 29. PMID: 26105609.
Copy Download .nbib Format: NLM
Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products.

Evidence-based complementary and alternative medicine : eCAM

Fuentes E, Palomo I.
PMID: 24324520
Evid Based Complement Alternat Med. 2013;2013:861786. doi: 10.1155/2013/861786. Epub 2013 Nov 13.

Platelets are no longer considered simply as cells participating in thrombosis. In atherosclerosis, platelets are regulators of multiple processes, with the recruitment of inflammatory cells towards the lesion sites, inflammatory mediators release, and regulation of endothelial function. The antiplatelet...

Cite
Fuentes E, Palomo I. Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products. Evid Based Complement Alternat Med. 2013;2013:861786doi: 10.1155/2013/861786.
Fuentes, E., & Palomo, I. (2013). Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products. Evidence-based complementary and alternative medicine : eCAM, 2013861786. https://doi.org/10.1155/2013/861786
Fuentes, Eduardo, and Palomo, Iván. "Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products." Evidence-based complementary and alternative medicine : eCAM vol. 2013 (2013): 861786. doi: https://doi.org/10.1155/2013/861786
Fuentes E, Palomo I. Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products. Evid Based Complement Alternat Med. 2013;2013:861786. doi: 10.1155/2013/861786. Epub 2013 Nov 13. PMID: 24324520; PMCID: PMC3845334.
Copy Download .nbib Format: NLM
Oral Implant Imaging: A Review.

The Malaysian journal of medical sciences : MJMS

Gupta S, Patil N, Solanki J, Singh R, Laller S.
PMID: 26715891
Malays J Med Sci. 2015 May-Jun;22(3):7-17.

Selecting an appropriate implant imaging technique has become a challenging task since the advent of advanced imaging modalities, and many of these are used for implant imaging. On imaging, the modality should not only consider the anatomy but should...

Cite
Gupta S, Patil N, Solanki J, et al. Oral Implant Imaging: A Review. Malays J Med Sci. 2015;22(3):7-17
Gupta, S., Patil, N., Solanki, J., Singh, R., & Laller, S. (2015). Oral Implant Imaging: A Review. The Malaysian journal of medical sciences : MJMS, 22(3), 7-17.
Gupta, Sarika, et al. "Oral Implant Imaging: A Review." The Malaysian journal of medical sciences : MJMS vol. 22,3 (2015): 7-17.
Gupta S, Patil N, Solanki J, Singh R, Laller S. Oral Implant Imaging: A Review. Malays J Med Sci. 2015 May-Jun;22(3):7-17. PMID: 26715891; PMCID: PMC4681716.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 674 entries